Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-05-24 @ 5:56 PM
Study NCT ID:
NCT03228667
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-17
First Post:
2017-07-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
Sponsor:
ImmunityBio, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Small Cell Lung Cancer | View |
| None | Small Cell Lung Cancer | View |
| None | Urothelial Carcinoma | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | Merkel Cell Carcinoma | View |
| None | Melanoma | View |
| None | Renal Cell Carcinoma | View |
| None | Gastric Cancer | View |
| None | Cervical Cancer | View |
| None | Hepatocellular Carcinoma | View |
| None | Microsatellite Instability | View |
| None | Mismatch Repair Deficiency | View |
| None | Colorectal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Pembrolizumab | View |
| None | Nivolumab | View |
| None | Non-Small Cell Lung Cancer (NSCLC) | View |
| None | Immunotherapy | View |
| None | Interleukin-15 | View |
| None | PD-1 Checkpoint Inhibitor | View |
| None | ALT-803 | View |
| None | Atezolizumab | View |
| None | Avelumab | View |
| None | Small Cell Lung Cancer (SCLC) | View |
| None | Urothelial Carcinoma | View |
| None | Head and Neck Squamous Cell Carcinoma (HNSCC) | View |
| None | Merkel Cell Carcinoma (MCC) | View |
| None | Melanoma | View |
| None | Renal Cell Carcinoma (RCC) | View |
| None | Gastric Cancer | View |
| None | Cervical Cancer | View |
| None | Hepatocellular Carcinoma (HCC) | View |
| None | Microsatellite Instability-High (MSI-H) | View |
| None | PD-L1 Checkpoint Inhibitor | View |
| None | Mismatch Repair Deficient (dMMR) Solid Tumor Cancer | View |
| None | Colorectal Cancer (CRC) | View |
| None | Durvalumab | View |
| None | PD-L1 t-haNK | View |
| None | N-803 | View |
| None | Keytruda | View |
| None | Opdivo | View |
| None | Imfinzi | View |
| None | Bavencio | View |
| None | Tecentriq | View |